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 Abstract: Background: Microemulsions are attractive delivery systems for therapeutic proteins and 
peptides due to their ability to enhance bioavailability. Although different proteins and peptides have 
been successfully delivered through such ternary systems, no information can be found about protein 
loading and the formulation stability when such microemulsions are prepared with pharmaceutically-
approved oils and surfactants. The aim of this work was to optimise a ternary system consisting of water/ 
ethyl oleate/SpanÒ 80-TweenÒ 80 and to determine its protein loading capacity and stability, using 
bovine serum albumin (BSA) as a model of biomolecule. 
Methods: The optimization was carried out using a Central Composite Design and all the prepared 
formulations were characterised through dynamic light scattering, rheology, optical and polarized mi-
croscopy. Subsequently, the maximum loading capacity was determined and the stability of the final 
microemulsion with the highest content of protein was followed over six months. To investigate the 
structural features of the protein, BSA was recovered from the microemulsion and analysed through 
fluorescence spectroscopy. 
Results: After incorporation of the protein in the microemulsion, a decrease of its aqueous solubility 
was observed. However, the formulation remained stable over six months and the native-like state of 
the recovered protein was demonstrated by fluorescence spectroscopy  
Conclusion: This study demonstrated the feasibility of preparing microemulsions with the highest con-
tent of protein and their long-term stability. 
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1. INTRODUCTION 
 Microemulsions are optically isotropic and thermody-
namically stable liquid systems [1], composed of water, oil 
and amphiphilic molecules, which find wide applications in 
several research fields (e.g. pharmaceutical, cosmetic and 
chemical industries) [2, 3]. 
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 In the pharmaceutical field, microemulsions have been 
proposed as drug delivery systems for different routes of 
administration [4, 5] due to their favourable properties, such 
as spontaneous formation, thermodynamic stability, drug 
solubility enhancement, low viscosity and the possibility to 
be sterilized [6-9]. Particularly, microemulsions which pre-
sent oil as the dispersant and water as the inner phase (some-
times referred as water in oil, i.e. w/o microemulsion or re-
verse micelles), have attracted interest by the scientific 
community since they could represent a suitable vehicle for 
the delivery of biological therapeutics [10]. In fact, formula-
tions of microemulsion systems for the oral delivery of ther-
apeutically-active peptides have already reached the market 
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(cyclosporine; Sandimmune Neoral®) or are under clinical 
trial evaluation (insulin, MacrulinTM) [11]. Their efficacy to 
improve the bioavailability of orally-administered macromo-
lecular drugs is related to the ability of protecting protein or 
peptides from acidic or enzymatic degradation or enhancing 
their intestinal absorption [12, 13].  
 Many biological products have been reported to be en-
capsulated in microemulsions [14-17]. Cheng et al. [18], 
demonstrated that a fibrinolytic enzyme, when incorporated 
in a w/o microemulsion, possesses a higher intestinal perme-
ability and efficacy in vivo, with the respect to the protein 
solution. Moreover, Liu et al. found that the HIV transactiva-
tor protein loaded in a w/o microemulsion, was protected 
against acid degradation [19]. The ability of w/o microemul-
sions to improve storage stability of proteins and catalytic 
activity of enzymes was also reported [20-22]. 
 However, to act as drug vehicles, the protein loading ca-
pacity and the folding state of the protein loaded inside the 
microemulsions are critical issues.  
 To date, most of the data on protein loading and formula-
tion stability are available only for microemulsions prepared 
with organic solvents (e.g. iso-octane) as external phase and 
high toxic surfactants (e.g. di-octyl sodium sulfosuccinate, 
AOT) [23-26]. On the contrary, there is a lack of information 
on microemulsions prepared with pharmaceutical grade ex-
cipients and potentially suitable for the in vivo administration 
of proteins or peptides. 
 In the present study, a microemulsion, prepared with a 
pharmaceutically-approved oil (as external phase) and sur-
factants, has been optimized using a response surface meth-
odology (RSM). Protein loading capacity and formulation 
stability at the highest content of the protein were studied 
using bovine serum albumin (BSA) as a model of a macro-
molecule. Due to the concerns related to the direct investiga-
tion of the state of the protein inside the microemulsion, 
BSA was recovered from the ternary system and analysed by 
SDS-PAGE and fluorescence spectroscopy. 
2. MATERIALS AND METHOD 
2.1. Materials  
 Ethyl oleate, Tween® 80 (Polysorbate 80) and Span® 80 
(Sorbitan monooleate) were supplied by ACEF (Fiorenzuola 
D’Arda, Italy). Sodium dodecyl sulphate (SDS) (BioReagent 
≥ 98.5%) and bovine serum albumin (purity >96%) were 
purchased by Sigma Aldrich (UK). Sodium chloride (NaCl), 
disodium hydrogen phosphate (Na2HPO4) and potassium 
dihydrogen phosphate (KH2PO4) were purchased from Carlo 
Erba (Italy). Deionised water was obtained using a laborato-
ry deionizer (Osmo lab UPW2, Gamma 3, Italy). Isotonic 
phosphate buffer at pH 7.4 was prepared by dissolving 
Na2HPO4 (22.2 mM) KH2PO4 (5.6 mM) and NaCl 123.3 mM 
in deionised water. 
2.2. Formulation of Microemulsions  
2.2.1. Experimental Design  
 Response Surface Methodology (RSM) is a reliable sta-
tistical approach through which it is possible to study how 
several factors affect the properties of a pharmaceutical for-
mulation, by generating a mathematical model to predict 
how the variation of such factors (independent-variables) 
influence one or more responses (dependent variables).  
 A “central composite design (CCD) was used to investi-
gate the influence of three factors (e.g. amount of water, 
amount of surfactant mixture Span® 80-Tween® 80 and total 
hydrophilic-lipophilic balance (HLB value) on droplets size, 
viscosity and stability of ternary systems made up of water/ 
ethyl oleate/Span® 80-Tween® 80.  
 The experiments necessary to study three factors systems 
through a CCD were the following: 
• 8 (23) factorial experiments, defined by the coded 
variables -1 or 1. 
• 6 (2*3) axial experiments, defined by the coded var-
iables -1.682 or +1.682. 
• 3 repetition of the central point, defined by the cod-
ed variable 0. 
 All the compositions prepared according to the experi-
mental design are listed in Table 1. 
 The results for each response were processed by a multi-
ple linear regression on the base of a full quadratic model: 
! = !"#$ + !!! + !!! + !!! + !!!!! + !!!!! + !!!!! + !!!! + !!!! + !!!! 
Eq. (1) 
 The significance of the regression and of the individual 
coefficients was determined by ANOVA analysis and t-test, 
respectively. Subsequently, this mathematical model was 
simplified by deletion of not significant terms.  
 Results were presented using contour plots for each re-
sponse and then optimized using the graphical method of the 
overlay plot. 
 More details concerning the CCD experimental plan and 
analysis can be found in the literature [27]. The experimental 
design and its statistical analysis were performed with the 
software MINITAB® Release 14.1 (Minitab Inc. 1972-2003). 
2.2.2. Sample Preparation 
 Tween® 80, Span® 80 and ethyl oleate were mixed to-
gether until a homogeneous system was obtained. Then, the 
relative amount of deionised water was added dropwise and 
the mixture was stirred for 6 h. Each system was stored in 
tight closed glass vial at 25°C for 24 hours before further 
use.  
2.2.3. Rheological Analysis 
 Viscometry tests were used to measure the viscosity of 
the samples at 25°C. All tests were performed by increasing 
the shear rate (γ) from 1 to 150 s-1 and the corresponding 
shear stress (σ) was measured, using a rotational rheometer 
(Stress–Tech, Rheologica, USA) equipped with a 4/40 cone-
plate geometry.  
 The shear rate vs shear stress curves was fitted by using 
the power law equation (equation 2) to calculate the power 
law viscosity (K) and the power law index (n). 
Water-in-Oil Microemulsions for Protein Delivery Current Pharmaceutical Biotechnology, 2017, Vol. 18, No. 5    3 
Table 1. List of the samples prepared according to the central composite design and relative coded and uncoded variables (surfac-
tant mixture %, water % and HLB index) values. 
Samples 
Coded Variables Uncoded Variables 
Surfactant Mixture (%) Water (%) HLB Index Surfactant Mixture (%) Water (%) HLB Index 
1 -1 -1 -1 20 8 9 
2 -1 +1 -1 20 12 9 
3 +1 -1 -1 30 8 9 
4 +1 +1 -1 30 12 9 
5 -1 -1 +1 20 8 13 
6 -1 +1 +1 20 12 13 
7 +1 -1 +1 30 8 13 
8 +1 +1 +1 30 12 13 
9 0 -1.682 0 25 6.64 11 
10 0 +1.682 0 25 13.36 11 
11 -1.682 0 0 16.59 10 11 
12 +1.682 0 0 33.41 10 11 
13 0 0 -1.682 25 10 7.64 
14 0 0 +1.682 25 10 14.64 
15 0 0 0 25 10 11 
16 0 0 0 25 10 11 
17 0 0 0 25 10 11 
 ! = !!!      Eq. (2) 
 All the analyses were performed in triplicate. 
2.2.4. Microscopy and Particle Size Analysis 
 All samples were observed with an optical polarised mi-
croscope (MT92000, Meiji Techno, JP) to identify whether 
the systems were nanodisperse and/or isotropic. When the 
samples were not isotropic, image analysis was used to 
measure the size of the droplets and/or surfactants aggregates 
in the micrometric range. Images of samples were collected 
using a 10X objective lens (MA832 U. Plan Objective 10X, 
Meiji Techno, JP) and a 3 megapixel camera (Invenio 3S, 
DeltaPix, DK). Size analyses were performed by using Im-
age Pro Plus Software (Media Cybernetics Inc., USA) meas-
uring the size of at least 100 particles e/o droplets.  
 The size of isotropic and nanodisperse systems, instead, 
was characterized by dynamic light scattering measurements 
(Zetasizer NanoS, Malvern, UK). 1 mL of the sample was 
loaded inside a disposable cuvette and analysed at 25°C after 
180 s for thermal equilibration. The size of the droplets was 
calculated according to the distribution model (Malvern 
Software), correcting the viscosity (10 mPa*s) and the refractive 
index (1.46) of the dispersant phase (ethyl oleate/Span® 80-
Tween® 80). Each sample was analysed in duplicate. 
2.2.5. Stability Test  
 All the samples prepared according to the experimental 
design were stored for six months at 25°C in tight closed 
glass vials. Stability was determined assigning to each sam-
ple a value corresponding to the time (months) required to 
turn from a transparent into a turbid or separate system.  
2.3. Hemolytic Assay 
 Hemolytic assay was performed to assess the hemolytic 
activity of the optimized microemulsions selected by the 
experimental design analysis. The test was performed for a 
general evaluation of the toxicological properties of the de-
signed formulations. Erythrocytes were collected from mice 
blood by centrifugation (6500 rpm for 10 min; 4°C), washed 
three times in an isotonic phosphate buffer solution. A stock 
suspension was prepared by suspending erythrocytes in the 
same buffer (cell density of 8x109 cells/ml). Different vol-
umes of microemulsions, from 5 µL to 500 µL, were tested 
against 25 µL of erythrocytes suspension. The final volume 
was adjusted to 1 ml with isotonic buffer. The negative con-
trol was prepared by suspending 25 µL of erythrocytes in 
950 µL of isotonic buffer, while the positive control was 
obtained with the same procedure of the negative one but 
finally frozen at -20°C [29]. All the samples, including posi-
tive and negative controls, were gently shaken for 10 
minutes at room temperature and centrifuged at 3000 rpm for 
5 min. Supernatant was collected and the absorbance was 
measured at 540 nm with a UV-Vis spectrometer (UV-1800, 
Shimadzu corporation). The extent of hemolysis, expressed 
as percentage (H%), was determined by using following 
equation: 
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! % = !"#!!!"#!"!"#!"!!"#!" · 100    Eq. (3) 
where: 
 AbsNC is the absorbance measured in the negative control 
(0% of hemolysis); 
 AbsPC is the absorbance measured in the positive control 
(100% of hemolysis); 
 AbsS is the absorbance measured in the samples contain-
ing the microemulsion. 
 The aqueous solution of the two surfactants (Span® 80 
and Tween® 80) at the same ratio used in the optimized mi-
croemulsion was tested for comparison. Furthermore, sodi-
um dodecyl sulphate (SDS) was used as an example of a 
well-characterised hemolytic surfactant. All samples were 
tested in triplicate.  
2.4. Microemulsion Loading Capacity 
 The maximum protein loading capacity, using BSA as 
model protein, was determined on the optimized formulation. 
BSA was dissolved inside the aqueous phase used for the 
microemulsion preparation according with the procedure 
reported in the section 2.2.2. The final BSA concentration 
ranged between 1 mg/ml and 24 mg/ml calculated with re-
spect to the total volume of the microemulsion.  
2.5. Characterization and Stability of BSA Loaded Mi-
croemulsion 
 The microemulsion loaded with the highest amount of 
BSA was characterized in terms of viscosity and size of the 
dispersed phase following the methodology previously de-
scribed (sections 2.2.3 and 2.2.4). All these parameters were 
monitored over a six months period at 4° and 25°C for stabil-
ity evaluation. 
2.6. Quantification of the BSA Recovery from the Micro-
emulsion 
 In order to recover the protein, 1 ml of the microemulsion 
loaded with the highest amount of BSA was diluted 1:5 with 
the extraction solution (water/acetonitrile 75:25) and gently 
mixed. The formed emulsion was centrifuged at 13000 rpm 
for 30 min at 4°C. The protein was recovered as pellets and 
resuspended in isotonic phosphate buffer (22.2 mM 
Na2HPO4, 5.6 mM KH2PO4 and 123.3 mM NaCl). The re-
covered protein was quantified through an image analysis of 
the electrophoretic bands obtained after a polyacrylamide 
electrophoresis performed under denaturing conditions 
(SDS-PAGE) and by fluorescence measurements.  
 SDS-PAGE was performed using 12% of polyacryla-
mide/bisacrylamide for the running gel and 3.5% for stack-
ing gel. 20 µL of the samples were boiled 5 min in the pres-
ence of 10 µL of sample loading buffer (1300 µL glycerol, 
1200µL of 10% SDS, 600 µl β-mercaptoethanol, 200 µL 
blue bromophenol saturated solution), subsequently loaded 
into the well of the stacking gel and run by applying a volt-
age of 200 V. After the running, protein bands were stained 
using Coomassie Brilliant blue R250 (5 grams dissolved in 
acetic acid/methanol/water 10:50:40) and the excess of the 
dye was removed using a destaining solution (acetic ac-
id/methanol/water 10:50:40). After destaining, the gel was 
scanned at 600 dpi resolution, and the gel image was ana-
lyzed using PDquest software (Version 7.1.1; Bio-Rad La-
boratories). Standard BSA solutions in the range of concen-
tration between 0.05 mg/mL and 1 mg/ml were also run in 
the same gel to build up a calibration curve. Three different 
samples of the resuspended BSA were run in three independ-
ent polyacrylamide gels together with standard solutions.  
 Fluorescence spectra of the recovered protein (diluted 1 
to 5 in buffer or in 6 M and 12 M urea) and standard solution 
of BSA in buffer phosphate at the same concentrations used 
in SDS-PAGE were collected at 25°C using a Hitachi 4500 
spectrofluorimeter. Samples were excited at 280 nm and the 
emission intensity was recorded in the range of 300-450 nm.  
 The recovery of the protein was expressed as percentage 
with the respect of the nominal loading of the microemul-
sion. 
3. RESULTS AND DISCUSSION 
3.1. Formulation of Microemulsions 
 The phase behaviour of ternary systems is generally stud-
ied by building a ternary phase diagram, which reports the 
results of a large number of experiments [28, 29]. However, 
a quicker screening of the factors influencing microemulsion 
formation can be performed by applying different type of 
design of experiments (DoE), such as factorial, fractional 
factorial, Hadamard or even central composite design.  
 In this work a response surface methodology, the central 
composite design (CCD), was employed since the number of 
the experimental factors to be analysed was limited and con-
sequently the number of experiments to be carried out can be 
kept low. 
 A CCD allows a mathematical description of the rela-
tionship between factors and response, assuring a better un-
derstanding of the process, as well as the possibility of the 
optimization of the process itself [27]. 
Table 2. Size (r. nm), viscosity (Pa*s) and stability (months) of the microemulsions prepared for the validation of the Central 
Composite Design (samples 18 and 19). 
Samples Size (r.nm) Power Law Viscosity (Pa*s) Stability (Months) 
18 40.85±1.77 0.87±0.01 > 3 
19 52.86±4.08 2.08±0.13 1.5 
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 The CCD was initially used to understand how the 
amount of water, of surfactant mixture and the surfactant 
ratio (HLB value) affected the systems properties such as the 
size of dispersed phase, the viscosity and the stability. 
 The presence of micrometric oil droplets in all the sam-
ples was evaluated by optical and polarised microscopy. For 
instance, water droplets in the micrometric range were ob-
served in several samples, e.g. sample 11 (Fig. 1A), indicat-
ing the formation of a coarse emulsified system at a macro-
scopic level. Conversely, other samples, e.g. number 7 (Fig. 
1B), appeared homogeneous under observation and conse-
quently were analysed using polarised light and DLS. Under 
polarised light, these samples did not show any birefrin-
gence, appearing as isotropic systems (Fig. 1C and 1D) and 
showed a monomodal size distribution in the nanometric 
range when analysed using DLS.  
 The effect of the three factors on the size of the dispersed 
phase was analysed with the CCD and the results were de-
scribed by the following model: 
 
Eq. (4) 
 The multilinear regression resulted to be significant 
(Pvalue = 0.016) when tested with ANOVA. The significant 
coefficients were only the amount of water (x1), the HLB 
value (x3) and the interaction between the amount of surfac-
tant and the HLB (x2x3) (SF1). The effect of x1 and x2 on the 
size, when the surfactant amount is kept constant at 30%, is 
reported in Fig. (2).  
 The second analysed response is the viscosity of the sys-
tems. All the formulations prepared showed different ap-
pearance, from transparent (sample 9) or white (sample 1) 
liquid, to white (sample 10) or transparent (sample 8) semi-
solid. When analysed with the viscometry test, the samples 
generated stress-strain traces with different trends, repre-
sentative of both Newtonian and non-Newtonian systems. 
For example, sample 1 had a power law index of around 1, 
typical of a Newtonian behaviour, while sample 7 showed a 




Fig. (2). Analysis of size response. Contour plot representing the 
effect of water (%) and total HLB on the size response of the Cen-
tral Composite Design. The parameter (surfactants %) is set at 30%. 
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Fig. (1). Microscopy analysis. Optical and polarised light microscope images (10X) of an emulsified system (sample 11) prepared according 
to the experimental design (A and C). Optical and polarised light microscope images (10X) of a homogeneous and isotropic system (sample 
7) prepared according to the experimental design (B and D). 
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 Examples of stress-strain traces of samples having differ-
ent rheological behaviour are reported in Fig. (3) (the figure 




Fig. (3). Rheological analysis. Flow curves from viscometry test 
performed on sample 1, 7 and 9 prepared according to the experi-
mental design. The figure shows the different rheological behaviour 
from Newtonian (sample 1) to pseudoplastic (samples 7 and 9). 
 
 The model describing the effect of the amount of water 
(x1), amount of surfactant mixture (x2) surfactants HLB (x3) 
on the power law viscosity (PLV) is reported below: 
 
Eq. (5) 
 The multilinear regression resulted to be significant 
(Pvalue = 0.014) when tested with the ANOVA, while all the 
coefficients were significant with the exception of x2 and the 
interactions x1x2 and x1x3 (SF2). As previously observed for 
the size, also in this case, the HLB value and water content 
were the most important factors. The increase of both pa-
rameters determines a raise of the consistency of the sys-
tems. The results of the CCD analysis are reported in Fig. (4) 
using the contour plot. 
 Finally, the stability of the systems was analysed. The 
formulations prepared according to the experimental design 
were stable for different periods after the end of the stirring, 
ranging from few minutes (samples 6 and 11) up to several 
months (samples 7 and 9), with intermediate values of few 
hours or days. 
 
 
Fig. (4). Analysis of viscosity response. Contour plot representing 
the effect of water (%) and total HLB on the viscosity response of 
the Central Composite Design. The third parameter (surfactants %) 
is set at 30%. 
 
 The model describing how the stability time (min) is in-
fluenced by the different factors is reported below: 
 
Eq. (6) 
 As for the others responses analysed, the multilinear re-
gression resulted to be significant (Pvalue = 0.011) when test-
ed with the ANOVA, while only the coefficients relative to 
the amount of water, both as linear and quadratic terms, were 
significant (SF3). The results of the CCD analysis, when the 
surfactant amount is kept constant at 30%, are reported in 
Fig. (5) using the contour plot.  
 The three determined models allowed understanding how 
the different factors affect each single response, which could 
be therefore optimized (find specific experimental conditions 
able to generate a certain response) individually. However, 
in order to obtain the best system, it is necessary to optimize 
all the three responses at the same time. To achieve this goal, 
the graphical optimization procedure was selected. Such pro-
cedure involves the superposition of each contour plot on top 
of each other in a single graph (overlay plot). The optimized 
systems are those having values of the responses all within 
the acceptability range. The acceptability limits were select-
ed to define the experimental conditions at which the size of 
the internal phase and the viscosity of the ternary systems 
were minimized, while the stability of the same system was 
maximized. By selecting a size (radius) for the internal phase 
lower than 300 nm, a power law viscosity lower than 0.5 
Pa*sec and a stability higher than three months (129600 
min), a feasibility area can be found only on the overlay plot 
water (%) vs. HLB with a total amount of surfactant at 30% 
(Fig. 6). From this specific overlay plot it can be observed 
that a suitable system can be formed only in a very narrow
323121321 606.0534.0264.0797.0245.0531.0824.0 xxxxxxxxxPLV ++++++=
2
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Fig. (5). Analysis of stability response. Contour plot representing 
the effect of water (%) and total HLB on the stability response of 
the Central Composite Design. The third parameter (surfactants 
%) is set at 30%. 
 
 
Fig. (6). Optimization of the ternary system. Overlay plot combin-
ing the effect of water (%) and total HLB on the three responses 
(size, viscosity and stability) of the Central Composite Design. 
The third parameter (surfactants %) is set at 30%. The red area in 
the graph represents the region inside the experimental domain 
where the size, viscosity and stability parameters of the micro-
emulsion are optimized. The black circle and triangle represent the 
composition of the two additional samples used for the validation 
of the central composite design. 
 
area (red area in the Fig. 6). Specifically, the HLB value has 
to be between 13.2 and 13.4 and the amount of water be-
tween 6.5% and 6.9% (lower amount are also possible but 
they are not taken into account since they are outside the 
experimental domain of the CCD) for a total amount of sur-
factant at 30%. 
 The effectiveness of the experimental design was validat-
ed by analysing two additional samples (samples 18 and 19). 
The first one was prepared using the experimental conditions 
inside the feasibility area whereas the second one using the 
conditions outside of it but within the limit of the size for a 
colloidal dispersion. The composition of these two formula-
tions (indicated in the Fig. (6) as black circle and triangle 
respectively) was as follows: 
 Sample 18: amount of water 6.7%, HLB value 13.3 and 
amount of surfactant mixture 30%; 
 Sample 19: amount of water 10%, HLB value 13.4 and 
amount of surfactant mixture 30%. 
 According with the overlay plot these two samples 
should possess similar size of the internal phase but different 
viscosity and stability.  
 These two samples were prepared with the same proce-
dure used for all the formulations of the experimental design 
and analysed as before. The experimental values for each 
response were quite close to those predicted by the overlay 
plot. Specifically, an increase in water content from 6.7 % to 
10% maintained the size of the internal phase below 0.5 µm, 
but determined a sharp increase in viscosity (from 0.87 to 
2.08 Pa*s). These results confirmed the validity of the pre-
diction model and consequently validated the effectiveness 
of the experimental design in the optimisation of the parame-
ters affecting the formulation of a ternary system. 
3.2. Haemolytic Assay 
 A general estimation of the toxicity of the two micro-
emulsions prepared for the validation of the experimental 
design (sample 18 and 19) was assessed by haemolytic as-
say. In addition, water solution of surfactant mixtures (Span® 
80-Tween® 80) at the same ratio used for the preparation of 
microemulsions number 18 and 19 were also tested. Fig. (7) 
shows the haemolysis (%) with respect to the tested volume 
of microemulsion or surfactant mixtures (µl). To this extent, 
it is known from the literature [29] that Tween® 80 is a non-
haemolytic surfactant, differently to Span 80 that exhibits 
moderate haemolytic properties [30]. The calculated hae-
molysis (%) was found to be much lower than 50% for both 
the microemulsions (around 5-10%) and surfactant mixtures 
(around 10-15%). Consequently, the HC50 values could not 
be calculated. Moreover, no difference between surfactant 
mixtures and microemulsions can be observed up to 150 µL 
8    Current Pharmaceutical Biotechnology, 2017, Vol. 18, No. 5 Perinelli et al. 
and just a slight increase in haemolysis for both the surfac-
tant mixtures occurred after the addition of 300-500 µL of 
samples. The accuracy of the method was evaluated by test-
ing SDS, a well-known haemolytic surfactant. In such case, 
increasing volumes of SDS solution (2 mg/mL) were tested 
up to 100% of haemolysis and the HC50 value was calculat-
ed. Such value (45 µg/mL) was comparable to that reported 
in the literature [30]. 
 
 
Fig. (7). Haemolytic assay. Haemolysis (%) versus sample volume 
(µL) of microemulsions prepared for the validation of the Central 
Composite Design (samples 18 and 19) in comparison to surfactant 
mixtures (Tween 80® and Span 80®) and SDS as reference. 
 
3.3. BSA Loading Capacity in Microemulsion 
 The evaluation of the loading capacity, especially in the 
case of proteins, is a neglected aspect in the formulation pro-
cess of microemulsions. Nevertheless, it is important to 
know how much protein can be loaded inside the internal 
aqueous phase when ternary systems are employed as vehi-
cles for the delivery of therapeutically-active protein through 
different routes of administration. 
 To this extent, an initial screening using BSA at a con-
centration between 24 mg/mL and 1 mg/mL was performed 
and the samples homogeneity was analysed through visual 
observation. All the systems prepared with a BSA concentra-
tion from 24 to 4 mg/mL appeared turbid just after the prepa-
ration, while microemulsions loaded with 1 mg/mL and 2 
mg/mL BSA appeared clear. All samples were, then, stored 
at 25°C. Significantly, after 48 h, a phase separation oc-
curred in the microemulsions displaying a BSA concentra-
tion from 24 mg/mL to 6 mg/mL. On the other hand, sam-
ples at 4 mg/ml, 2 mg/ml and 1 mg/ml of BSA concentration 
did not show any observable changes when compared to the 
same samples just after the preparation. 4 mg/mL BSA mi-
croemulsion remained turbid, instead, 2 mg/L and 1 mg/mL 




Fig. (8). BSA loading capacity in the microemulsion. Visual obser-
vation after a 48 h of storage time at 25°C of the microemulsion, 
selected according to the Central Composite Design (sample 18) 
and prepared at different BSA concentrations from 24 mg/mL to 1 
mg/mL (A) and from 6 mg/mL to 1 mg/mL (B). 
 
 The samples were also analysed through optical micros-
copy to examine whether the presence of BSA could destabi-
lize the microemulsion. From the pictures in Fig. (9), it can 
be observed that there is no presence of large (>1 µm) drop-
lets at any BSA concentration after the preparation, denoting 
that the presence of the protein did not cause the coalescence 
of the internal phase of the microemulsion. However, sam-
ples that appeared turbid at the visual inspection, showed the 
presence of insoluble particles. The amount of these particles 
markedly decreased from 24 mg/mL BSA-microemulsion 
(Fig. 9A) to 6 mg/mL BSA-microemulsion (Fig. 9B) sug-
gesting that, at those concentrations, the protein precipitated. 
Microemulsions at 1 mg/mL and 2 mg/mL appeared clear 
also under microscopic observation (Fig. 9C). From these 
results, it can be deduced that BSA does not disrupt micro-
emulsion structure, but the turbidity of samples is only due 
to protein precipitation.  
 In order to confirm this hypothesis, the upper and the 
lower phase of 48 h stored samples, in which a phase separa-
tion occurred, were collected and observed by optical mi-
croscopy. The upper phase appeared clear in all samples 
(Fig. 9D); the lower phase, instead, showed insoluble parti-
cles (Fig. 9E) appearing quite similar to those observed in 
the same sample immediately after the preparation.  
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 It is interesting to note that the solubility of BSA in pure 
water is very different from the solubility of BSA in the wa-
ter entrapped in microemulsion. In fact, all stock solutions of 
the protein in water, from which BSA-loaded microemul-
sions were prepared, appeared clear or slightly yellowish 
depending on protein concentration, but no precipitation 
event occurred within 48 h at room temperature.  
 On the contrary, when these solutions were incorporated 
in the oily phase a marked reduction of solubility was ob-
served. A decrease in solubility, leading to protein precipita-
tion at a certain time after the incorporation inside the micro-
emulsions, has also been reported for AOT-isooctane-water 
ternary systems [31-33]. 
 Solubility of BSA in water (no particles were observed 
through optical microscope after 48 h of storage time) was 
found higher than 358 mg/mL, which is the concentration of 
BSA solution used to prepare the microemulsion loaded with 
24 mg/mL of the protein. Interestingly, if we consider the 
solubility of BSA respect to water, when incorporated inside 
the microemulsion, it decreased to around 29 mg/mL. Thus, 
the confinement of water inside a microemulsion and/or the 
presence of high amount of surfactant caused the desolvation 
of the protein (BSA >2 mg/mL of the total volume of the 
microemulsion) and consequently its precipitation at a con-
centration of protein higher than 6 mg/mL. This is probably 
due to the fact that water molecules in a ternary systems are 
mostly bounded on surfactants molecules and are less avail-
able to be engaged in solvation shells around the solutes, 
especially in the case of macromolecules as proteins [34,35]. 
Comparable solubility values for proteins (lysozyme and 
chymotrypsin) around 1-2 mg/ml were found in microemul-
sions prepared with organic solvents [23]. 
3.4. Storage Stability of BSA-loaded Microemulsion 
 The effect of the storage time and temperature (25°C and 
4°C) on the stability of the sample 18 loaded with the highest 
amount of BSA (2 mg/mL) was investigated by visual and 
microscopic inspection, DLS measurements and viscometry 
 
 
Fig. (9). BSA loading capacity in the microemulsion. Optical microscope images (10X) of BSA-loaded microemulsions after the preparation: 
24 mg/mL (A), 6 mg/mL (B) and 2 mg/mL (C). Images of the upper phase (D) and lower phase (E) from 24 mg/ml BSA-loaded microemul-
sion after storage 48 h at 25°C. 
 
Table 3. Viscosity (Pa*s), power law index value (n) and size (r. nm) for the optimized microemulsion (sample 18) and the same 
microemulsion loaded with 2 mg/mL of BSA, calculated after preparation and after storage at 25°C and 4°C for six 
months. 
	   Viscosity (Pa*s) Index (n) Size (r.nm) 
Microemulsion 0.870±0.120 0.568±0.013 40.85±1.77 
BSA-loaded microemulsion 0.970±0.155 0.571±0.032 42.82±3.50 
Microemulsion stored 6 months at 25°C 0.902±0.160 0.554±0.021 40.66±2.86 
BSA-loaded microemulsion stored 6 months at 25°C 0.992±0.127 0.595±0.024 45.25±4.26 
Microemulsion stored 6 months at 4°C 1.292±0.151 0.465±0.049 44.30±4.05 
BSA-loaded microemulsion stored 6 months at 4°C 1.283±0.172 0.464±0.017 49.63±6.84 
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test. The obtained results were compared to those obtained 
from the same systems without the protein in order to assess 
if the presence of the protein at the maximum solubility level 
can affect microemulsion stability.  
 All the samples remained transparent and isotropic dur-
ing all the stability period at the two tested temperatures 
when visually observed or analysed under microscopy. Table 
3 reports the value for power law viscosity, power law index 
and size for both free or BSA-loaded microemulsion after 
preparation and after storage at 4°C and 25°C for six months. 
The presence of BSA at the maximum solubilisation level (2 
mg/ml) did not increase the size of internal droplets both 
after preparation and after the storage at 25°C and 4°C. The 
same behaviour has also been observed for BSA-free micro-
emulsion. Moreover, the loading of BSA did not change the 
viscosity of the system nor its pseudoplastic behaviour 
(power law index ≈ 0.5). A slight increase of the viscosity 
(from 0.9 to 1.2 Pa*s) was only observed for the samples 
stored at 4°C both for loaded and unloaded samples. Taken 
together, the analysis of macroscopic properties (appearance, 
viscosity) and the measurement of the droplet size of the 
microemulsion demonstrated the thermodynamic stability of 




Fig. (10). Quantification of BSA recovery from microemulsion by 
SDS-PAGE. (A) SDS-PAGE gel: a-c lanes are the recovered pro-
tein in isotonic phosphate buffer, d-f lanes are BSA standard solu-
tions in isotonic phosphate buffer at different concentrations (from 
0.05 mg/mL to 1 mg/mL). (B) Calibration curve build up by plot-
ting the pixel intensity of the electrophoretic bands relative to BSA 
standard solution at different concentrations. 
 
 
Fig. (11). Fluorescence spectra of the recovered BSA from micro-
emulsion in isotonic phosphate buffer, 6M and 12M urea water 
solutions. 
 
3.5. Quantification of the Recovered BSA 
 The protein recovered by the microemulsion loaded with 
the maximum amount of BSA was quantified through the 
spot image analysis of the gel from SDS-PAGE (densitomet-
ric analysis) as described before. This technique was widely 
employed in molecular biology or proteomics [36], but its 
use is yet underestimated for protein quantitative analysis in 
pharmaceutics.  
 Figure 10A showed the scanned polyacrylamide gel from 
electrophoresis. The lanes a-c refer to the samples from mi-
croemulsions in triplicates, while the lanes d-g refer to 
standard solution of BSA at the concentration range 0.1-1 
mg/ml. It can be noticed from the lanes referring to BSA 
standard solutions (d-g), the presence of the main high inten-
sity band (indicated by and arrow in the figure) related to the 
to the 66 kDa fraction of the protein and a secondary less-
coloured band at a slighter low molecular weight (BSA puri-
ty ≥ 96% from the manufacturer). Nevertheless, when the 
protein is overloaded inside the gel (f-g; concentration ≥ 0.5 
mg/mL) several fainted bands of different molecular weights 
appeared. According to the literature, the bands at molecular 
weight lower than 66 kDa can be identified as BSA peptide 
fragments, while those at higher molecular weight as dimeric 
or trimeric forms of the protein [37,38].  
 As shown in the figure 10B, a linear dependence of the 
pixel intensity of the main band obtained from the running of 
BSA standard solutions at different concentrations was ob-
served and used to build up the calibration curve. The R2 of 
the fitting linear regression curve obtained from the BSA 
standard solution in the three independent gels was higher 
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than 0.976. Using these calibration curves, the percentage of 
the recovered BSA from microemulsion (69.37± 6.65%) was 
calculated by the estimation of the pixel intensity of the main 
band.  
 Interestingly, the recovered BSA showed bands with 
shorter electrophoretic path with higher intensity than BSA 
standard used for the calibration curve. These bands can be 
ascribed to the formation of protein aggregates due to a 
polymerization process [39]. In order to understand if these 
differences in the electrophoretic pattern are due to the con-
dition of the protein inside the microemulsion or to the re-
covery process, SDS-PAGE was also performed on the pro-
tein solution treated with the same extraction mixture (wa-
ter/acetonitrile 75:25) and then centrifuged (30 min, 13000 
rpm). In this case, the bands relative to the aggregates of the 
protein were of less intensity with respect to those observed 
by running the protein extracted from the microemulsion 
(SF4). This result confirms that the extraction process does 
not influence the aggregation state of BSA. 
 The quantification of the protein was also performed by 
fluorescence measurements. A calibration curve using stand-
ard solution of BSA in isotonic buffer was built (R2>0.997) 
(SF5). The calculated recovery was 51.66 ± 3.1%. As it can 
be observed from the fluorescence spectra (Figure 11) the 
maximum emission wavelength of the recovered BSA (dilut-
ed 1 to 5 in isotonic buffer) is around 340 nm, which is com-
parable to that of a native protein. When urea as denaturing 
agent is added, the recovered protein showed the characteris-
tic spectral changes of a pure BSA solution as reported in the 
literature [40]. In particular, in presence of 6 M of urea a 
blue shift from 340 nm to 334 nm occurred due to a change 
in the hydrophobicity in the microenvironment around tryp-
tophans. Instead, by increasing the concentration of urea up 
to 12 M a red shift occurred to 346 nm due to the unfolding 
of the protein and the exposure of tryptophan residues to the 
solvent’s hydrophilic environment. Overall, fluorescence 
spectra confirmed the maintenance of a native-like state of 
the recovered protein. 
CONCLUSION 
 In this work, a stable and non-toxic microemulsion sys-
tem made up of water/ethyl oleate/ Span®80-Tween®80 was 
optimized through a central composite design and loaded 
with the maximum amount of the protein. Our results sug-
gest that the confinement of water, as in a microemulsion 
system, strongly affects the solubility of the protein, when 
compared with its aqueous solution. Particularly, a marked 
decrease in water solubility of the protein was observed after 
incorporation in the microemulsion. This aspect should be 
considered anytime when such systems are formulated for 
the delivery of macromolecules, as biotherapeutics. Moreo-
ver, the formulation showed a long-term stability, also when 
the protein was incorporated close to the saturation point in 
the aqueous compartment, suggesting the feasibility of pre-
paring microemulsions at the highest content of proteins. 
Finally, a method for the recovery of the protein from a mi-
croemulsion formulated with approved oil and surfactants 
has been proposed and the native-like behaviour of the re-
covered BSA as a model of macromolecules, has been 
demonstrated through SDS-PAGE and fluorescence spec-
troscopy. 
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